Concepedia
Statistics
Publications
7
Citations
303
H-Index
Active since
2011
Affiliations
Xenon Pharmaceuticals (Canada)(Current)
Volgograd State Medical University
Chemical Diversity Research Institute
Mikhail Chafeev is an author at Xenon Pharmaceuticals (Canada) specializing in pharmacology, medicinal chemistry, and medicine.
Publications per year
2011–2018
Discovery of XEN907, a spirooxindole blocker of NaV1.7 for the treatment of pain
Sultan Chowdhury, Mikhail Chafeev, Shifeng Liu et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 156 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +8
Discovery of benzylisothioureas as potent divalent metal transporter 1 (DMT1) inhibitors
Zaihui Zhang, Kodumuru Vishnumurthy, Serguei Sviridov et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 37 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +12
The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Nav1.7
Shaoyi Sun, Qi Jia, Alla Zenova et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 36 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +16
Tetracyclic spirooxindole blockers of hNaV1.7: activity in vitro and in CFA-induced inflammatory pain model
Sultan Chowdhury, Shifeng Liu, Jay A. Cadieux et al. · Medicinal Chemistry Research · 2012 · 36 citations
Medicine, Medicinal Chemistry, Pharmacology +12
ZB-16, a Novel GPR119 Agonist, Relieves the Severity of Streptozotocin–Nicotinamide-Induced Diabetes in Rats
I. N. Tyurenkov, Mikhail Chafeev · Frontiers in Endocrinology · 2017 · 14 citations · Full text
Medicine, Endocrinology, Pharmacology +17
1–5 of 7